Skip to content

CapEx at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$21.76M+73.0%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$69K
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
$3.85M
AbbVie logo
AbbVieABBV
$265M+12.8%
Revvity logo
RevvityRVTY
$19.78M+23.7%
ALN
Alnylam PharmaceuticalsALNY

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$11.52B+402%
Enterprise value$11.44B+418%
P/S18.5×+14.3×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Arrowhead Research’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arrowhead Research's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arrowhead Research's capex?
Arrowhead Research (ARWR) reported capex of $2.57M in Q1 2026.
How has Arrowhead Research's capex changed year-over-year?
Arrowhead Research's capex decreased by 51.6% year-over-year, from $5.3M to $2.57M.
What is the long-term trend for Arrowhead Research's capex?
Over 4 years (2021 to 2025), Arrowhead Research's capex has grown at a -1.0% compound annual growth rate (CAGR), from $23.57M to $22.67M.
What does capex mean?
Cash spent on purchasing or upgrading long-term physical assets.
How do you interpret capex?
High spending indicates growth and infrastructure investment, while low spending may signal cost-cutting or a mature asset base.
How does capex compare across companies?
Essential for comparing the intensity of infrastructure investment among peer biotech firms.